Preclinical and clinical pharmacology of biotherapeutic agents:: Saccharomyces boulardii

被引:16
作者
Periti, P [1 ]
Tonelli, F [1 ]
机构
[1] Univ Florence, I-50121 Florence, Italy
关键词
probiotics; prebiotics; biotherapeutics; living drugs; S; boulardii;
D O I
10.1179/joc.2001.13.5.473
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Probiotic agents are living microorganisms that, upon ingestion, exert health benefits beyond inherent general nutrition. In this context, we must differentiate between biotherapeutics as approved drugs and dietary supplements and food products containing probiotic bacteria that are not considered drugs. At present the only biotherapeutic agent which is prescribable in some European countries, indicated to relieve specific diseases, is the yeast Saccharomyces, boulardii. In this review we consider the various preclinical and clinical aspects of biotherapeutics as basic drugs and the biotherapeutic powers of their use in the treatment of some surgical enteropathies.
引用
收藏
页码:473 / 493
页数:21
相关论文
共 146 条
[1]  
ADAM P, 1976, MED CHIRURG DIGESTIV, V5, P401
[2]   ON THE SAFETY OF LACTIC-ACID BACTERIA FROM FOOD [J].
ADAMS, MR ;
MARTEAU, P .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1995, 27 (2-3) :263-264
[3]   LACTIC-ACID BACTERIA AND HUMAN CLINICAL INFECTION [J].
AGUIRRE, M ;
COLLINS, MD .
JOURNAL OF APPLIED BACTERIOLOGY, 1993, 75 (02) :95-107
[4]  
Alander M, 1999, APPL ENVIRON MICROB, V65, P351
[5]   Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy:: A pilot study [J].
Armuzzi, A ;
Cremonini, F ;
Ojetti, V ;
Bartolozzi, F ;
Canducci, F ;
Candelli, M ;
Santarelli, L ;
Cammarota, G ;
De Lorenzo, A ;
Pola, P ;
Gasbarrini, G ;
Gasbarrini, A .
DIGESTION, 2001, 63 (01) :1-7
[6]   The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy [J].
Armuzzi, A ;
Cremonini, F ;
Bartolozzi, F ;
Canducci, F ;
Candelli, M ;
Ojetti, V ;
Cammarota, G ;
Anti, M ;
De Lorenzo, A ;
Pola, P ;
Gasbarrini, G ;
Gasbarrini, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (02) :163-169
[7]   CLOSTRIDIUM-DIFFICILE - CLINICAL CONSIDERATIONS [J].
BARTLETT, JG .
REVIEWS OF INFECTIOUS DISEASES, 1990, 12 :S243-S251
[8]   Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas [J].
Bartlett, JG .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (11) :1054-1061
[9]   ANTIBIOTIC-ASSOCIATED DIARRHEA [J].
BARTLETT, JG .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (04) :573-581
[10]   ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS DUE TO TOXIN-PRODUCING CLOSTRIDIA [J].
BARTLETT, JG ;
CHANG, TW ;
GURWITH, M ;
GORBACH, SL ;
ONDERDONK, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (10) :531-534